{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:39:39Z","timestamp":1787787579892,"version":"build-2784847793"},"reference-count":17,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to investigate the prevalence and genetic relatedness of multidrug-resistant Gram-negative bacilli, particularly those resistant to carbapenems, in patients admitted to intensive care units. It also sought to explore associations between bacterial colonization or infection and clinical outcomes, including comorbidities, treatment regimens, and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between November 2022 and December 2023, screening and pathological samples were collected from patients at a tertiary hospital. Screening samples included rectal and pharyngeal swabs, while pathological samples comprised respiratory tract secretions. Bacterial identification and antibiotic susceptibility testing were performed using standard microbiological methods. Genetic similarity among isolates was assessed using a molecular fingerprinting technique to detect potential clonal spread.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 62 carbapenem-resistant strains were identified, with Acinetobacter baumannii and Klebsiella pneumoniae being the most prevalent. Pathological isolates exhibited higher resistance levels than screening isolates. Most patients had multiple comorbidities, with cardiac, renal, and pulmonary conditions being the most common. A significant association was found between prolonged intensive care unit stay and increased mortality. However, no significant correlation was observed between the number of comorbidities or antibiotic classes used and mortality. Molecular analysis revealed clonal clusters of Acinetobacter and Klebsiella strains, suggesting nosocomial transmission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings underscore the importance of early screening, molecular surveillance, and stringent infection control measures in intensive care settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/jccm-2025-0048","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T15:00:06Z","timestamp":1762441206000},"page":"347-356","source":"Crossref","is-referenced-by-count":4,"title":["Epidemiological insights into carbapenem resistant infections in critical care settings: A molecular and clinical investigation"],"prefix":"10.2478","volume":"11","author":[{"given":"Camelia","family":"Vintila","sequence":"first","affiliation":[{"name":"George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures , Targu Mures , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan Lucian","family":"Coseriu","sequence":"additional","affiliation":[{"name":"George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures , Targu Mures , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru Andrei","family":"Ujlaki Nagi","sequence":"additional","affiliation":[{"name":"Mures County Clinical Hospital , Targu Mures , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Man","sequence":"additional","affiliation":[{"name":"George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures , Targu Mures , Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"2025111916093249415_j_jccm-2025-0048_ref_001","doi-asserted-by":"crossref","unstructured":"Medina E, Pieper DH. Tackling Threats and Future Problems of Multidrug-Resistant Bacteria. Curr Top Microbiol Immunol 2016;398:3\u201333. DOI: 10.1007\/82_2016_492.","DOI":"10.1007\/82_2016_492"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_002","doi-asserted-by":"crossref","unstructured":"Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. The Lancet 2024;404:1199\u2013226. DOI: 10.1016\/S0140-6736(24)01867-1.","DOI":"10.1016\/S0140-6736(24)01867-1"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_003","unstructured":"Antimicrobial resistance n.d. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance (accessed June 30, 2025)."},{"key":"2025111916093249415_j_jccm-2025-0048_ref_004","doi-asserted-by":"crossref","unstructured":"Bhattacharya S. Is screening patients for antibiotic-resistant bacteria justified in the Indian context? Indian J Med Microbiol 2011;29:213\u20137. DOI: 10.4103\/0255-0857.83902.","DOI":"10.4103\/0255-0857.83902"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_005","doi-asserted-by":"crossref","unstructured":"Rice LB. Controlling antibiotic resistance in the ICU: different bacteria, different strategies. Cleve Clin J Med 2003;70:793\u2013800. DOI: 10.3949\/ccjm.70.9.793.","DOI":"10.3949\/ccjm.70.9.793"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_006","doi-asserted-by":"crossref","unstructured":"Blot S, Rupp\u00e9 E, Harbarth S, Asehnoune K, Poulakou G, Luyt C-E, et al. Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive Crit Care Nurs 2022;70:103227. DOI: 10.1016\/j.iccn.2022.103227.","DOI":"10.1016\/j.iccn.2022.103227"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_007","doi-asserted-by":"crossref","unstructured":"Seifi K, Kazemian H, Heidari H, Rezagholizadeh F, Saee Y, Shirvani F, et al. Evaluation of Biofilm Formation Among Klebsiella pneumoniae Isolates and Molecular Characterization by ERIC-PCR. Jundishapur J Microbiol 2016;9:e30682. DOI: 10.5812\/jjm.30682.","DOI":"10.5812\/jjm.30682"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_008","unstructured":"eucast: Previous versions of documents n.d. https:\/\/www.eucast.org\/ast_of_bacteria\/previous_versions_of_documents (accessed July 31, 2025)."},{"key":"2025111916093249415_j_jccm-2025-0048_ref_009","doi-asserted-by":"crossref","unstructured":"Chatelut M, Dournes JL, Chabanon G, Marty N. Epidemiological typing of Stenotrophomonas (Xanthomonas) maltophilia by PCR. J Clin Microbiol 1995;33:912\u20134. DOI: 10.1128\/jcm.33.4.912-914.1995.","DOI":"10.1128\/jcm.33.4.912-914.1995"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_010","doi-asserted-by":"crossref","unstructured":"Bar Ilan M, Kjerulf A. Who should be screened for carbapenemase-producing Enterobacterales and when? A systematic review. J Hosp Infect 2023;142:74\u201387. DOI: 10.1016\/j.jhin.2023.09.018.","DOI":"10.1016\/j.jhin.2023.09.018"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_011","doi-asserted-by":"crossref","unstructured":"Abramowicz L, Gerard M, Martiny D, Delforge M, De Wit S, Konopnicki D. Infections due to carbapenemase-producing bacteria, clinical burden, and impact of screening strategies on outcome. M\u00e9decine Mal Infect 2020;50:658\u201364. DOI: 10.1016\/j.medmal.2019.12.011.","DOI":"10.1016\/j.medmal.2019.12.011"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_012","doi-asserted-by":"crossref","unstructured":"R\u00e4is\u00e4nen K, Lyytik\u00e4inen O, Kauranen J, Tarkka E, Forsblom-Helander B, Gr\u00f6nroos JO, et al. Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012\u20132018. Eur J Clin Microbiol Infect Dis 2020;39:1651\u20136. DOI: 10.1007\/s10096-020-03885-w.","DOI":"10.1007\/s10096-020-03885-w"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_013","doi-asserted-by":"crossref","unstructured":"Otter JA, Mookerjee S, Davies F, Bolt F, Dyakova E, Shersing Y, et al. Detecting carbapenemase-producing Enterobacterales (CPE): an evaluation of an enhanced CPE infection control and screening programme in acute care. J Antimicrob Chemother 2020;75:2670\u20136. DOI: 10.1093\/jac\/dkaa192.","DOI":"10.1093\/jac\/dkaa192"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_014","doi-asserted-by":"crossref","unstructured":"Vincent J-L, Sakr Y, Singer M, Martin-Loeches I, Machado FR, Marshall JC, et al. Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. JAMA 2020;323:1478\u201387. DOI: 10.1001\/jama.2020.2717.","DOI":"10.1001\/jama.2020.2717"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_015","doi-asserted-by":"crossref","unstructured":"Campion M, Scully G. Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation. J Intensive Care Med 2018;33:647\u201355. DOI: 10.1177\/0885066618762747.","DOI":"10.1177\/0885066618762747"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_016","doi-asserted-by":"crossref","unstructured":"Londero A, Costa M, Sucari A, Leotta G. Comparison of three molecular subtyping techniques for Listeria monocytogenes. Rev Argent Microbiol Argent J Microbiol 2019;51:359\u201362. DOI: 10.1016\/j.ram.2019.01.003.","DOI":"10.1016\/j.ram.2019.01.003"},{"key":"2025111916093249415_j_jccm-2025-0048_ref_017","doi-asserted-by":"crossref","unstructured":"Co\u0219eriu RL, Vintil\u0103 C, Mare AD, Ciurea CN, Tog\u0103nel RO, Cighir A, et al. Epidemiology, Evolution of Antimicrobial Profile and Genomic Fingerprints of Pseudomonas aeruginosa before and during COVID-19: Transition from Resistance to Susceptibility. Life 2022;12:2049. DOI: 10.3390\/life12122049.","DOI":"10.3390\/life12122049"}],"container-title":["The Journal of Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.sciendo.com\/pdf\/10.2478\/jccm-2025-0048","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T16:09:45Z","timestamp":1763568585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciendo.com\/article\/10.2478\/jccm-2025-0048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":17,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,10,31]]},"published-print":{"date-parts":[[2025,10,1]]}},"alternative-id":["10.2478\/jccm-2025-0048"],"URL":"https:\/\/doi.org\/10.2478\/jccm-2025-0048","relation":{},"ISSN":["2393-1817"],"issn-type":[{"value":"2393-1817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}